Skip to main content
. 2019 Sep 6;25(2):121–e213. doi: 10.1634/theoncologist.2019-0599
Dose level Dose of drug: Alpha‐1,3‐galactosyltransferase‐expressing allogeneic renal cell carcinoma immunotherapy No. enrolled No. evaluable for toxicity
1 150,000,000 cells 4 4
2 300,000,000 cells 14 14

graphic file with name ONCO-25-121-g003.jpg